Conduit Pharmaceuticals reports advancements in lupus studies and trial designs. The Company partnered with Charles River ...

Discover whether AbbVie or Sanofi holds the edge in the global immunology market and find out which stock shows more ...

Aligos Therapeutics is a clinical-stage biotechnology company focused on improving patient outcomes through best-in-class ...

Manipal Hospital Vijayawada has successfully diagnosed and treated a rare case of Sjögren’s Syndrome affecting the brain, a ...

While acute hepatitis B infection is often resolved by the immune system, CHB occurs when the body's defences are unable to ...

(THE CONVERSATION) Nearly every modern medical treatment can be traced to research funded by the National Institutes of Health: from over-the-counter and prescription medications that treat high ...

In June 2024, the sNDA for TUOYI ® in combination with paclitaxel for injection (albumin-bound) for the first-line treatment ...

On January 28, 2025, the Company received clearance of its IND from the FDA to initiate a first-in-human Phase 1 dose ...

G Protein-Coupled Receptors (GPCRs) in advancing GPCR-targeted therapies, including the use of agonists, antagonists, biased ...

“ Psoriasis is an inflammatory skin disorder, due to an overactive immune system,” said Dr. Omar Noor. “That over active immune system produces inflammation in the skin that causes the skin to develop ...

Favorable initial results from a phase 1/2 trial of solnerstotug in PD-L1–resistant tumors showed a 14% response rate and 62% ...